Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Jong Sun Park, MD
- Email: jspark.im@gmail.com
Study Contact Backup
- Name: Seok-Chul Yang, MD, PhD
- Phone Number: +82-2-2072-0354
- Email: scyang@snu.ac.kr
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Recruiting
- Seoul National University Hospital
-
Contact:
- Jong Sun Park, MD
- Email: jspark.im@gmail.com
-
Contact:
- Seok-Chul Yang, MD
- Email: scyang@snu.ac.kr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients (aged 18 years or older) admitted to the Respiratory Department
Exclusion Criteria:
- outpatient procedures
- therapeutic bronchoscopy
- expected operation or discharge within 24 hours after the FB
- sedative premedication
- endotracheal intubation with mechanical ventilation
- inability to speak Korean
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Placebo 1T by mouth (po) at night one day before FB and placebo 1T po 30min before the FB
|
Placebo 1T po at night one day before FB and placebo 1T po 30min before the FB
|
|
Experimental: Lorazepam
Lorazepam 0.5mg po at night one day before FB and Lorazepam 1mg po 30min before the FB
|
Lorazepam 0.5mg po at night one day before FB and Lorazepam 1mg po 30min before the FB
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
patient satisfaction
Time Frame: within 24 hr of bronchoscopy
|
within 24 hr of bronchoscopy
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
relationship between patient satisfaction and sleep quality, anxiety level
Time Frame: 24hr before and after bronchoscopy
|
24hr before and after bronchoscopy
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Seok-Chul Yang, MD, Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Antiemetics
- Gastrointestinal Agents
- Tranquilizing Agents
- Psychotropic Drugs
- Hypnotics and Sedatives
- Anti-Anxiety Agents
- GABA Modulators
- GABA Agents
- Anticonvulsants
- Lorazepam
Other Study ID Numbers
Other Study ID Numbers
- Lorazepam in FB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.